Recursion Pharmaceuticals Inc (RXRX)
7.865
+0.02
(+0.32%)
USD |
NASDAQ |
Apr 26, 11:14
Recursion Pharmaceuticals Price: 7.865 for April 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 25, 2024 | 7.57 | 7.885 | 7.48 | 7.84 | 4.307M |
| Apr 24, 2024 | 8.15 | 8.27 | 7.89 | 7.94 | 7.206M |
| Apr 23, 2024 | 7.56 | 7.92 | 7.55 | 7.70 | 5.111M |
| Apr 22, 2024 | 7.46 | 7.79 | 7.205 | 7.60 | 3.946M |
| Apr 19, 2024 | 7.30 | 7.44 | 7.135 | 7.35 | 4.014M |
| Apr 18, 2024 | 7.35 | 7.58 | 7.27 | 7.40 | 2.862M |
| Apr 17, 2024 | 7.64 | 7.71 | 7.43 | 7.47 | 3.508M |
| Apr 16, 2024 | 7.61 | 7.77 | 7.51 | 7.57 | 3.848M |
| Apr 15, 2024 | 8.41 | 8.458 | 7.77 | 7.79 | 5.149M |
| Apr 12, 2024 | 8.80 | 8.925 | 8.315 | 8.41 | 3.428M |
| Apr 11, 2024 | 8.65 | 8.94 | 8.50 | 8.92 | 3.149M |
| Apr 10, 2024 | 8.61 | 8.778 | 8.41 | 8.58 | 3.752M |
| Apr 09, 2024 | 9.00 | 9.22 | 8.95 | 9.09 | 2.596M |
| Apr 08, 2024 | 8.91 | 9.12 | 8.79 | 9.00 | 3.129M |
| Apr 05, 2024 | 8.534 | 8.94 | 8.41 | 8.87 | 3.413M |
| Apr 04, 2024 | 9.02 | 9.33 | 8.71 | 8.73 | 4.724M |
| Apr 03, 2024 | 8.85 | 9.35 | 8.723 | 8.93 | 6.047M |
| Apr 02, 2024 | 8.96 | 9.00 | 8.67 | 8.77 | 6.851M |
| Apr 01, 2024 | 9.98 | 9.98 | 9.33 | 9.37 | 6.625M |
| Mar 28, 2024 | 10.10 | 10.28 | 9.94 | 9.97 | 5.442M |
| Mar 27, 2024 | 10.35 | 10.42 | 10.07 | 10.17 | 3.999M |
| Mar 26, 2024 | 10.61 | 10.89 | 10.31 | 10.32 | 5.067M |
| Mar 25, 2024 | 10.51 | 10.91 | 10.41 | 10.53 | 3.831M |
| Mar 22, 2024 | 10.51 | 10.79 | 10.29 | 10.49 | 3.695M |
| Mar 21, 2024 | 11.20 | 11.45 | 10.26 | 10.65 | 8.042M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.56
Minimum
May 02 2023
41.33
Maximum
Jul 13 2021
12.81
Average
9.64
Median
Nov 04 2022
Price Benchmarks
| Eli Lilly and Co | 734.73 |
| Palatin Technologies Inc | 1.695 |
| Oragenics Inc | 1.03 |
| Editas Medicine Inc | 5.29 |
| BioXcel Therapeutics Inc | 2.555 |
Price Related Metrics
| PS Ratio | 37.17 |
| PEG Ratio | -0.3432 |
| Price to Book Value | 3.982 |
| Earnings Yield | -19.96% |
| Market Cap | 1.846B |
| PEGY Ratio | -0.3432 |